Warfarin-Induced Pseudo-Allergy

Nikhat B. Syed, Ralph Marktanner, Derar Gharaibeh

Abstract


Most common adverse reactions to warfarin are fatal and nonfatal hemorrhage from any tissue or organ. Despite bleeding complications being the most feared concern, non-bleeding events can also occur from warfarin therapy. These non-bleeding events, which account for less than 1%, include but are not limited to skin necrosis and dermatological hypersensitivity reactions. We describe a rare case of “warfarin allergy” in a 77-year-old female patient admitted for coronary bypass grafting and mitral/aortic valve replacement. The patient came with a history of valvular heart disease, embolism (occlusion of distal superficial femoral artery) and atrial fibrillation with documented “warfarin allergy” described as dermatitis and anaphylaxis witnessed during earlier hospital admission. Given double valve replacement and atrial fibrillation (CHA2DS2-VASc score of 9), she was deemed a candidate for lifelong warfarin. Significant renal impairment and recent valve replacement narrowed the choice of anticoagulant to warfarin. To rule out the possibility of dye allergy, patient was re-challenged with dye free warfarin with close monitoring. Patient was able to tolerate dye free (white) warfarin with no allergic manifestation. The purpose of this report is to increase awareness of possibility of allergic reaction to dye in medications and recommend possibility of dye free medications as an option in such cases.




J Hematol. 2014;3(4):116-117
doi: http://dx.doi.org/10.14740/jh173w

Keywords


Warfarin; Pseudo-allergy; Adverse reaction

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!